Janssen will also highlight its commitment to transform cancer care with more than 90 presentations showcasing robust, differentiated portfolio and pipeline in hematologic malignancies and solid tumours.
Data presented at EuroPCR 2023 build on prior study results demonstrating Abbott's TriClip is a safe and effective therapy to treat leaky tricuspid valves.
The FDA approval was backed by Abbott's DISTINCT study, the largest randomized controlled trial for spinal cord stimulation (SCS) in people with chronic back pain when surgery is not an option.
Mercurius Health’s newly-acquired Robert Janker Klinik will be equipped with state-of-the-art diagnostic and therapeutic oncology solutions from Philips and Elekta.